Simulations Plus, Inc. (NASDAQ:SLP) Shares Bought by Verition Fund Management LLC

Verition Fund Management LLC lifted its holdings in Simulations Plus, Inc. (NASDAQ:SLP) by 120.5% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,365 shares of the technology company’s stock after purchasing an additional 5,665 shares during the period. Verition Fund Management LLC owned about 0.05% of Simulations Plus worth $332,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. BNP Paribas Financial Markets grew its holdings in shares of Simulations Plus by 402.9% in the 3rd quarter. BNP Paribas Financial Markets now owns 39,944 shares of the technology company’s stock worth $1,279,000 after acquiring an additional 32,002 shares during the last quarter. Quantbot Technologies LP purchased a new position in Simulations Plus in the 3rd quarter worth about $59,000. Pitcairn Co. raised its holdings in Simulations Plus by 9.1% during the 3rd quarter. Pitcairn Co. now owns 6,599 shares of the technology company’s stock worth $211,000 after buying an additional 549 shares during the period. First Horizon Advisors Inc. lifted its stake in Simulations Plus by 82.6% during the third quarter. First Horizon Advisors Inc. now owns 818 shares of the technology company’s stock valued at $26,000 after buying an additional 370 shares in the last quarter. Finally, Mutual of America Capital Management LLC boosted its holdings in shares of Simulations Plus by 18.7% in the third quarter. Mutual of America Capital Management LLC now owns 85,275 shares of the technology company’s stock worth $2,731,000 after buying an additional 13,418 shares during the period. 78.08% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the stock. William Blair restated an “outperform” rating on shares of Simulations Plus in a report on Wednesday, November 6th. BTIG Research reduced their target price on Simulations Plus from $60.00 to $50.00 and set a “buy” rating for the company in a report on Thursday, October 24th. Stephens began coverage on Simulations Plus in a report on Friday, November 15th. They set an “overweight” rating and a $39.00 price target on the stock. Finally, StockNews.com downgraded Simulations Plus from a “hold” rating to a “sell” rating in a research note on Monday, November 4th. One analyst has rated the stock with a sell rating, one has issued a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $51.40.

Simulations Plus Trading Down 3.1 %

Shares of NASDAQ:SLP opened at $30.93 on Friday. The firm has a market cap of $620.77 million, a price-to-earnings ratio of 63.12 and a beta of 0.76. Simulations Plus, Inc. has a 1 year low of $27.07 and a 1 year high of $51.22. The business has a fifty day simple moving average of $30.79 and a 200 day simple moving average of $36.55.

Simulations Plus (NASDAQ:SLP) last posted its quarterly earnings results on Wednesday, October 23rd. The technology company reported $0.06 earnings per share for the quarter, topping analysts’ consensus estimates of $0.04 by $0.02. The company had revenue of $18.70 million during the quarter, compared to the consensus estimate of $19.73 million. Simulations Plus had a return on equity of 6.16% and a net margin of 14.15%. The business’s quarterly revenue was up 19.9% on a year-over-year basis. During the same period last year, the business earned $0.18 EPS. On average, sell-side analysts forecast that Simulations Plus, Inc. will post 1.1 EPS for the current year.

Insiders Place Their Bets

In other news, Director Walter S. Woltosz sold 20,000 shares of the company’s stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $31.76, for a total transaction of $635,200.00. Following the completion of the sale, the director now owns 3,442,584 shares in the company, valued at approximately $109,336,467.84. This represents a 0.58 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders sold 60,750 shares of company stock valued at $1,837,255 over the last ninety days. Corporate insiders own 20.90% of the company’s stock.

Simulations Plus Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.